Human papilloma virus vaccines and their role in cancer prevention

Discusses the reasons why the human papilloma virus (HPV) vaccine, which helps with the prevention of cervical cancer, should be publically funded. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Comm...

Full description

Saved in:
Bibliographic Details
Published inNew Zealand medical journal Vol. 120; no. 1266; p. U2829
Main Authors Jones, Ronald W, Coughlan, Edward P, Reid, J Stewart, Sykes, Peter, Watson, Peter D, Cook, Catherine
Format Journal Article
LanguageEnglish
Published New Zealand 30.11.2007
Subjects
Cancer
Cancer vaccines
Causality
Cervical Intraepithelial Neoplasia - epidemiology
Cervical Intraepithelial Neoplasia - prevention & control
Cervix uteri
Comorbidity
Condylomata Acuminata - epidemiology
Condylomata Acuminata - prevention & control
Female
Humans
Immunization Programs - trends
Incidence
Male
New Zealand - epidemiology
Papillomavirus Infections - epidemiology
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines
Prevalence
Prevention
Risk Factors
United States - epidemiology
Uterine Cervical Neoplasms - epidemiology
Uterine Cervical Neoplasms - prevention & control
Vaccination
New Zealand
United States
Online AccessGet full text

Cover

More Information
Summary:Discusses the reasons why the human papilloma virus (HPV) vaccine, which helps with the prevention of cervical cancer, should be publically funded. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.
Bibliography:Archived by the National Library of New Zealand
Refs
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0028-8446
1175-8716
1175-8716